IRLAB Therapeutics AB (publ) (IRLAB-A) — Financial Flexibility Index
IRLAB Therapeutics AB (publ) (IRLAB-A) has a Financial Flexibility Index of -0.22x as of December 2025. Free cash flow of Skr-24.18 Million (operating CF Skr-24.18 Million minus capex Skr0.00) represents 0% of total liabilities (Skr107.49 Million). Check IRLAB-A cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
IRLAB Therapeutics AB (publ) Financial Flexibility Index (2014–2025)
Historical Financial Flexibility Index trend for IRLAB Therapeutics AB (publ) across 12 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of IRLAB Therapeutics AB (publ).
Annual Financial Flexibility Index for IRLAB Therapeutics AB (publ) (2014–2025)
Year-by-year free cash flow to debt coverage for IRLAB Therapeutics AB (publ). Explore IRLAB Therapeutics AB (publ) cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.51x | Skr-55.22 Million | Skr-55.22 Million | Skr107.49 Million | ▲ +18.6% |
| 2024 | -0.63x | Skr-65.39 Million | Skr-65.59 Million | Skr103.58 Million | ▲ +76.5% |
| 2023 | -2.68x | Skr-164.56 Million | Skr-164.85 Million | Skr61.36 Million | ▲ +37.0% |
| 2022 | -4.25x | Skr-139.24 Million | Skr-142.61 Million | Skr32.72 Million | ▼ -340.0% |
| 2021 | 1.77x | Skr129.35 Million | Skr128.64 Million | Skr72.97 Million | ▲ +144.3% |
| 2020 | -4.00x | Skr-88.82 Million | Skr-89.21 Million | Skr22.19 Million | ▼ -15.3% |
| 2019 | -3.47x | Skr-91.06 Million | Skr-91.20 Million | Skr26.24 Million | ▲ +38.0% |
| 2018 | -5.60x | Skr-69.74 Million | Skr-70.79 Million | Skr12.46 Million | ▲ +22.4% |
| 2017 | -7.22x | Skr-57.52 Million | Skr-57.74 Million | Skr7.97 Million | ▼ -63.9% |
| 2016 | -4.40x | Skr-40.60 Million | Skr-40.82 Million | Skr9.22 Million | ▼ -44.3% |
| 2015 | -3.05x | Skr-27.66 Million | Skr-27.66 Million | Skr9.06 Million | ▼ -394.1% |
| 2014 | -0.62x | Skr-11.02 Million | Skr-11.02 Million | Skr17.86 Million | — |